COVID-19 state of vaccine confidence insights report ; report 15, October 15, 2021
Public Domain
-
October 15, 2021
-
File Language:
English
Details
-
Corporate Authors:
-
Description:Date Range: September 14 – 27, 2021
Summary
Findings. President Biden’s September 9, 2021 call for COVID-19 vaccine requirements continued to drive social media conversations, news articles, and responses from politicians opposed to the requirements. In summary, there continues to be vocal opposition among a segment of social media users to the announcement and general workplace vaccine requirements. The US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted on September 17, 2021, to approve the administration of COVID-19 vaccine booster doses. On September 24, CDC’s Advisory Committee on Immunization Practices (ACIP) also approved the administration of COVID-19 vaccine booster doses. On September 20, 2021, Pfizer and BioNTech announced they submitted data to the FDA on COVID-19 vaccine trial data in children ages 5 to 11 years. This announcement was accompanied by increased consumer interest in vaccinating children including when they will be available and safety and efficacy data. Finally, consumers continued to exhibit interest in safety and efficacy data on booster doses and where they could find them.
Ways to take action. Federal, state, and local partners should continue to work together to explain the rationale for updated guidance, respond to gaps in information, and confront misinformation with evidence-based messaging. The goal of these efforts is to increase confidence in COVID-19 vaccines and expand vaccine uptake more broadly. Employers should provide periodic updates to employees on how vaccination requirements have helped reduce the spread of COVID-19 in the workplace.
Public health organizations should create and disseminate public health messaging that presents data on the safety and efficacy of other childhood vaccines for kids ages 5 to 11 years and the COVID-19 vaccine in children 12 years and older. Professional associations and public health organizations should develop materials and tools for healthcare providers to share with their patients about the benefits of receiving a booster dose and when and how to get a booster dose. These communications should include information addressing concerns about the risks of severe side effects.
CS000000-A | 10/15/21
SoVC_report16.pdf
-
Subjects:
-
Series:
-
Document Type:
-
Genre:
-
Pages in Document:8 numbered pages
-
Collection(s):
-
Main Document Checksum:urn:sha-512:ae1303310e43b3a962b8da782eb3ec7270f0215e6f3d77934efe3e48c1cc59e97e892ff583f51b25ea3d6a16d22652ae4bef86c3bc6bc91789b046a96ca29585
-
Download URL:
-
File Type:
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Stephen B. Thacker CDC Library